Simon Nichols1, Alasdair F O'Doherty2, Claire Taylor3, Andrew L Clark4, Sean Carroll5, Lee Ingle5. 1. Centre for Sports and Exercise Science, Sheffield Hallam University, Sheffield, UK. 2. Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle-Upon-Tyne, UK. 3. Carnegie School of Sport, Leeds Beckett University, Leeds, UK. 4. Academic Cardiology, Castle Hill Hospital, Cottingham, UK. 5. Sport Health and Exercise Science, University of Hull, Hull, UK.
Abstract
BACKGROUND: In patients with chronic heart failure, there is a positive linear relationship between skeletal muscle mass (SMM) and peak oxygen consumption ( V ˙ O2peak ); an independent predictor of all-cause mortality. We investigated the association between SMM and V ˙ O2peak in patients with coronary heart disease (CHD) without a diagnosis of heart failure. METHODS: Male patients with CHD underwent maximal cardiopulmonary exercise testing and dual X-ray absorptiometry assessment. V ˙ O2peak, the ventilatory anaerobic threshold and peak oxygen pulse were calculated. SMM was expressed as appendicular lean mass (lean mass in both arms and legs) and reported as skeletal muscle index (SMI; kg m-2 ), and as a proportion of total body mass (appendicular skeletal mass [ASM%]). Low SMM was defined as a SMI <7·26 kg m-2 , or ASM% <25·72%. Five-year all-cause mortality risk was calculated using the Calibre 5-year all-cause mortality risk score. RESULTS: Sixty patients were assessed. Thirteen (21·7%) had low SMM. SMI and ASM% correlated positively with V ˙ O2peak (r = 0·431 and 0·473, respectively; P<0·001 for both). SMI and ASM% predicted 16·3% and 12·9% of the variance in V ˙ O2peak , respectively. SMI correlated most closely with peak oxygen pulse (r = 0·58; P<0·001). SMI predicted 40·3% of peak V ˙ O2 /HR variance. ASM% was inversely associated with 5-year all-cause mortality risk (r = -0·365; P = 0·006). CONCLUSION: Skeletal muscle mass was positively correlated with V ˙ O2peak in patients with CHD. Peak oxygen pulse had the strongest association with SMM. Low ASM% was associated with a higher risk of all-cause mortality. The effects of exercise and nutritional strategies aimed at improving SMM and function in CHD patients should be investigated.
BACKGROUND: In patients with chronic heart failure, there is a positive linear relationship between skeletal muscle mass (SMM) and peak oxygen consumption ( V ˙ O2peak ); an independent predictor of all-cause mortality. We investigated the association between SMM and V ˙ O2peak in patients with coronary heart disease (CHD) without a diagnosis of heart failure. METHODS: Male patients with CHD underwent maximal cardiopulmonary exercise testing and dual X-ray absorptiometry assessment. V ˙ O2peak, the ventilatory anaerobic threshold and peak oxygen pulse were calculated. SMM was expressed as appendicular lean mass (lean mass in both arms and legs) and reported as skeletal muscle index (SMI; kg m-2 ), and as a proportion of total body mass (appendicular skeletal mass [ASM%]). Low SMM was defined as a SMI <7·26 kg m-2 , or ASM% <25·72%. Five-year all-cause mortality risk was calculated using the Calibre 5-year all-cause mortality risk score. RESULTS: Sixty patients were assessed. Thirteen (21·7%) had low SMM. SMI and ASM% correlated positively with V ˙ O2peak (r = 0·431 and 0·473, respectively; P<0·001 for both). SMI and ASM% predicted 16·3% and 12·9% of the variance in V ˙ O2peak , respectively. SMI correlated most closely with peak oxygen pulse (r = 0·58; P<0·001). SMI predicted 40·3% of peak V ˙ O2 /HR variance. ASM% was inversely associated with 5-year all-cause mortality risk (r = -0·365; P = 0·006). CONCLUSION: Skeletal muscle mass was positively correlated with V ˙ O2peak in patients with CHD. Peak oxygen pulse had the strongest association with SMM. Low ASM% was associated with a higher risk of all-cause mortality. The effects of exercise and nutritional strategies aimed at improving SMM and function in CHD patients should be investigated.
Authors: Daniel J Wilkinson; Giovanny Rodriguez-Blanco; Warwick B Dunn; Bethan E Phillips; John P Williams; Paul L Greenhaff; Kenneth Smith; Iain J Gallagher; Philip J Atherton Journal: Aging (Albany NY) Date: 2020-06-24 Impact factor: 5.682
Authors: Hsiu-Hsi Chiang; Po-Fu Lee; Yun-Tsung Chen; Chi-Fang Lin; Shu Xu; Yi-Tien Lin; Yu-Ting Lin; Yan-Jhu Su; Ben-Chang Shia; Wen-Sheng ChangChien; Chien-Chang Ho Journal: Int J Environ Res Public Health Date: 2022-07-21 Impact factor: 4.614
Authors: Richard Kirwan; Deaglan McCullough; Tom Butler; Fatima Perez de Heredia; Ian G Davies; Claire Stewart Journal: Geroscience Date: 2020-10-01 Impact factor: 7.713